Therefore, we conducted a meta-analysis to verify whether lncRNA MALAT-1 expression was associated with prognosis or clinicopathological features in patients with non-small cell lung cancer (NSCLC). This evidence concerns the gene MALAT1 and non-small cell lung carcinoma.